Naslov
BMP1.3 protein as potential target in treatment of fibrosis

Autori
Bordukalo Nikšić, Tatjana ; Kufner, Vera

Izvornik
Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti (1330-5301) 548 (2021), 56-57; 56-69

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni

Ključne riječi
bone morphogenetic protein 1 (BMP1) ; fibrosis ; procollagen ; transforming growth factor ; chronic kidney disease

Sažetak
Bone morphogenetic protein 1 (BMP1) belongs to the procollagen C proteinase (PCP) family of proteases involved in development and pattern formation in various organisms. BMP1 proteinases mediate the cleavage of carboxyl peptides from procollagen molecules, which is a crucial step in fibrillar collagen synthesis. From six described alternatively spliced variants of human Bmp1 gene, only BMP1.3 protein was detected in human plasma and elevated plasma levels of this protein were found in pathological conditions such as chronic kidney disease and acute myocardial infarction. Since BMP1 is required to convert pro-collagen to collagen, its inhibition is a potential intervention for treating fibrosis. Inhibition of BMP1.3 was shown to decrease the progression of liver fibrosis in an animal model of liver cirrhosis. One of the major inflammatory signaling molecules involved in fibrogenesis in various organs is transforming growth factor beta 1 (TGFβ1), which expression is elevated in various models of induced fibrosis. Many studies have revealed that BMP1 proteases play a key role in regulation of TGFβ activation. Here, we discuss BMP1.3 inhibition as a potential treatment in different pathological conditions related to the fibrosis. Testing BMP1.3 inhibition in these models indicates that the anti-BMP1.3 antibody targets relevant pathways in the development of fibrosis in different organs.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA